Phase II study of hypofractionated stereotactic body radiation therapy for prostate cancer
Not Applicable
Recruiting
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000014671
- Lead Sponsor
- Radiation Oncology, Tokai University Hachioji Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have had any other cancer within the past 5 years 2)Patients who have uncontrollable diabetes mellitus 3)Patients who have serious comorbidities such as collagen disease, heart disease, interstitial pneumonia, liver cirrhosis 4)patients who have a psychological problem 5)patients who had previously received pelvic irradiation 6)patients who had previously received pelvic surgery 7)patients who had previously received TURP, orchiectomy, or HIFU 8)patients who had previously received chemotherapy for prostate cancer 9)patients who have Crohn's disease or ulcerative colitis 10)patients who require concomitant anticoagulant therapy 11)IPSS at registration>=20
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method